TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth quarter and full year 2024 BRIUMVI U.S. net revenue of $103.6 million and $310 million, respectivelyTarget guidance of approximately $540 ...